Laninamivir octanoate hydrate structure
|
Common Name | Laninamivir octanoate hydrate | ||
---|---|---|---|---|
CAS Number | 1233643-88-3 | Molecular Weight | 490.55 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C21H38N4O9 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Laninamivir octanoate hydrateLaninamivir octanoate hydrate (CS-8958 hydrate), a prodrug of Laninamivir, is a long-acting neuraminidase (NA) inhibitor with anti-influenza virus activity. Laninamivir octanoate hydrate shows anti-influenza activity against Oseltamivir-resistant viruses, and also against the pandemic influenza viruses[1][2]. |
Name | (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-2-hydroxy-1-methoxy-3-octanoyloxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid,hydrate |
---|---|
Synonym | More Synonyms |
Description | Laninamivir octanoate hydrate (CS-8958 hydrate), a prodrug of Laninamivir, is a long-acting neuraminidase (NA) inhibitor with anti-influenza virus activity. Laninamivir octanoate hydrate shows anti-influenza activity against Oseltamivir-resistant viruses, and also against the pandemic influenza viruses[1][2]. |
---|---|
Related Catalog | |
In Vitro | Laninamivir octanoate (CS-8958) 对 H1N1 病毒株、H3N2 病毒株和 H2N2 (A/Singapore/1/57) 病毒株具有抑菌活性,IC50 分别为 631-1170 nM、39.2-221 nM 和 128 nM [1]。 |
In Vivo | Laninamivir octanoate (CS-8958;95μg/kg;鼻内的管理;3 次) 在感染前 4 h、感染后 4 h 和 17 h 处理,在小鼠感染模型中均有明显的延长寿命效果[1]。 Animal Model: Female BALB/c mice (5-6 weeks old) infected with influenza A virus A/PR/8/34[1] Dosage: 0.2 μmol/kg (95 μg/kg) Administration: Intranasal administration; three dose; at 4 h before and 4 h and 17 h postinfection Result: Showed life-prolonging effect in infected model. |
References |
Molecular Formula | C21H38N4O9 |
---|---|
Molecular Weight | 490.55 |
Exact Mass | 490.26400 |
PSA | 206.01000 |
LogP | 1.95660 |
UNII-MCG28BI87W |
Laninamivir octanoate hydrate (JAN) |
Laninamivir octanoate monohydrate |